Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity

J Courjon, O Dufies, A Robert, L Bailly, C Torre… - Blood …, 2021 - ashpublications.org
Dysregulated immune response is the key factor leading to unfavorable coronavirus disease
2019 (COVID-19) outcome. Depending on the pathogen-associated molecular pattern, the …

A vicious cycle: in severe and critically Ill COVID-19 patients

P Huang, Q Zuo, Y Li, PK Oduro, F Tan… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus, is one of the fastest-evolving viral diseases …

Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies

Q He, D Hu, F Zheng, W Chen, K Hu, J Liu, C Yao, H Li… - Viruses, 2024 - mdpi.com
The coronavirus disease 2019 (COVID-19) global pandemic, caused by severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2), has been marked by severe cases …

Inflammasome activation in COVID-19 patients

TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra… - MedRxiv, 2020 - medrxiv.org
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …

[HTML][HTML] Common NLRP3 inflammasome inhibitors and Covid-19: divide and conquer

GES Batiha, AI Al-Gareeb, D Rotimi, OS Adeyemi… - Scientific African, 2022 - Elsevier
Severe SARS-CoV-2 infection causes systemic inflammation, cytokine storm, and
hypercytokinemia due to activation of the release of pro-inflammatory cytokines that have …

Novel coronavirus-induced NLRP3 inflammasome activation: a potential drug target in the treatment of COVID-19

A Shah - Frontiers in immunology, 2020 - frontiersin.org
Novel coronaviruses (nCoVs) encode ion-channel proteins called viroporins such as protein
E, open reading frame 3a (ORF3a) and ORF8a. These viroporins, via mechanisms such as …

[HTML][HTML] Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

TS Rodrigues, KSG de Sá, AY Ishimoto… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Severe cases of COVID-19 are characterized by a strong inflammatory process that may
ultimately lead to organ failure and patient death. The NLRP3 inflammasome is a molecular …

The inflammasome in times of COVID-19

JC de Rivero Vaccari, WD Dietrich, RW Keane… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses (CoVs) are members of the genus Betacoronavirus and the Coronaviridiae
family responsible for infections such as severe acute respiratory syndrome (SARS), Middle …

SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells

A Villacampa, E Alfaro, C Morales… - Cell Communication and …, 2024 - Springer
Background Hyperinflammation, hypercoagulation and endothelial injury are major findings
in acute and post-COVID-19. The SARS-CoV-2 S protein has been detected as an isolated …

Coagulation disorders in COVID-19: role of toll-like receptors

I Biswas, GA Khan - Journal of Inflammation Research, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world.
The range of the disease is broad but among hospitalized patients with COVID-19 are …